Popular Articles

India favours legally binding agreement from developed world
India today favoured a legally binding climate change agreement from the developed countries saying a political pact will not be "enforceable", even as it asserted that its voluntary reduction of carbon emission intensity was not announced under pressure.

Magma Fincorp picks up 7 per cent in Experian India
Magma Fincorp Limited, a leading asset finance company, has picked up seven per cent stake in Experian Credit Information Company of India Pvt Ltd, the Indian Credit Information Company (CIC) arm of the global information services company, Experian.

News of the day

Jaiprakash Power Ventures to raise Rs 1,500-2,000 cr
Jaypee Group firm Jaiprakash Power Ventures today said it will raise Rs 1,500-2,000 crore through convertible bonds issued to foreign investors and institutional placement by next month to augment its generation capacity.
Business Opportunities

Sun Pharma unit gets USFDA nod for anti-allergic drug

Drug firm Sun Pharma today said it has received the US regulator"s approval for the generic version of Acular, used to treat pain and swelling after eye surgeries. - Caraco looking at shifting production to India - Sun Pharma accuses Taro director of misusing funds - Sun Pharma net profit dips 11.5% - "We are not a topline-driven company" - Sun Pharma profit dips 11.49% - Bhupesh Bhandari: The new pharmaceutical order">Bhupesh Bhandari: The new pharmaceutical order The US Food and Drug Administrator (USFDA) has granted approval for the Abbreviated New Drug Application (ANDA) for the generic version of Acular, which is also known as Ketotrolac Tromethamine Opthalmic Solution, Sun Pharma said in a filing to the Bombay Stock Exchange. US-based drug firm Allergan Inc has patent rights over Ketotrolac Tromethamine Opthalmic Solution and the company is selling the drug under the brand Acular. The drug is indicated for the temporary relief of ocular itching due to seasonal allergic conductivities, it said.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):